Tox Tech Competitors

At BASF, we create chemistry for a sustainable future. Our ambition: We want to be the preferred chemical company to enable our customers’ green transformation. We combine economic success with environmental protection and social responsibility. Around 108,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises, as core businesses, the segments Chemicals, Materials, Industrial Solutions, and Nutrition & Care; our standalone businesses are bundled in the segments Surface Technologies and Agricultural Solutions. BASF generated sales of around €60 billion in 2025. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/global/en/legal/credits Data protection information: https://www.basf.com/global/en/legal/data-protection-at-basf.html

U.S. Environmental Protection Agency’s (EPA) mission is to protect human health and the environment. EPA works to ensure that: - Americans have clean air, land and water; - National efforts to reduce environmental risks are based on the best available scientific information; - Federal laws protecting human health and the environment are administered and enforced fairly, effectively and as Congress intended; - Environmental stewardship is integral to U.S. policies concerning natural resources, human health, economic growth, energy, transportation, agriculture, industry, and international trade, and these factors are similarly considered in establishing environmental policy; - All parts of society--communities, individuals, businesses, and state, local and tribal governments--have access to accurate information sufficient to effectively participate in managing human health and environmental risks; - Contaminated lands and toxic sites are cleaned up by potentially responsible parties and revitalized; and - Chemicals in the marketplace are reviewed for safety. The agency was founded in 1970 and is headquartered in Washington, District of Columbia with ten additional regional headquarters offices (Boston, New York, Philadelphia, Atlanta, Chicago, Dallas, Kansas City, Denver, San Francisco, and Seattle) as well as more than a dozen laboratories, and other regional and programmatic offices.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.